Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.
You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.
Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Bioage Labs (NASDAQ:BIOA), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO) and Milestone Pharmaceuticals (NASDAQ:MIST).
Nektar Therapeutics has a consensus price target of $4.22.
The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $0.9008 last updated December 23, 2024 at 6:00 PM EST.
There are no upcoming dividends for Nektar Therapeutics.
Nektar Therapeutics’s Q4 earnings are confirmed for Monday, March 3, 2025.
There is no upcoming split for Nektar Therapeutics.
Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.